Attached files

file filename
8-K - FORM 8-K - Nexeo Solutions Holdings, LLCd488994d8k.htm

Exhibit 99.1

Nexeo Solutions Holdings, LLC

Management EBITDA Reconciliation

(in thousands)

 

     Q2 FY12     Q3 FY12      Q4 FY12     Q1 FY13     LTM  

Net income (loss) attributable to Nexeo Solutions Holdings, LLC

   $ 7,230      $ 6,601       $ (5,401   $ (14,674   $ (6,244

Net income attributable to noncontrolling interest

     —          —           —          159        159   

Interest

     11,487        11,103         11,268        13,720        47,578   

Taxes

     1,341        766         555        757        3,419   

Depreciation and amortization

     10,824        9,378         9,801        9,554        39,557   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

EBITDA

     30,882        27,848         16,223        9,516        84,469   

Management add-backs (1)

     8,528        7,467         9,707        7,477        33,179   

Non-cash charges (2)

     (303     355         108        1,420        1,580   

Management fees (3)

     1,553        1,691         2,301        1,715        7,260   

Letter of credit fees not included in interest expense

     48        327         230        —          605   

Compensation expense related to management equity plan (non-cash)

     754        326         278        240        1,598   

Transitional pension and medical payments – Ashland employees (4)

     118        145         68        —          331   

Transaction and other one-time costs (5)

     2,148        804         3,572        9,262        15,786   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

Adjusted Management EBITDA

   $ 43,728      $ 38,963       $ 32,487      $ 29,630      $ 144,808   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

 

(1) One-time costs associated with integration, transition, restructuring and transformational activities
(2) Non-cash charges include unrealized foreign exchange gains and losses and amortization charges associated with purchase accounting requirements related to the acquisition of Beijing Plaschem’s operations
(3) Management, monitoring, consulting and leverage fees, per the agreement with TPG Capital, L.P.
(4) Transitional pension and medical payments owed to certain Ashland employees pursuant to the Agreement of Purchase and Sale, dated November 5, 2010 by and between Ashland and Nexeo Solutions, LLC (formerly TPG Accolade, LLC), as amended
(5) Professional and transaction costs related to the acquisition of the global distribution business of Ashland, the China joint venture, other potential acquisitions and other one-time costs